Actemra Binding Assays

BioOutsource has extensive experience in the development, optimization and qualification of a wide range of different types of binding assays and immunoassays, and offers GLP and cGMP-compliant testing services in compliance with EMA and FDA guidelines to support the biopharmaceutical industry.

Using this experience, we have created a range of biosimilar off-the-shelf binding assays. Binding assays are employed to study a number of different features of Actemra/RoActemra (tocilizumab) and play a vital role in the development process, and characterization and comparability of biosimilar molecules.  BioOutsource offer the following assays to support the characterization of Actemra (tocilizumab):

BioOutsource offers cost-effective solutions to develop custom methods that are not currently in our portfolio; please contact us to find out more.

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy